Advertisement

Forensic Toxicology

, 25:62 | Cite as

GC-MS detection and characterization of thebaine as a urinary marker of opium use

  • Babiker M. El-HajEmail author
  • Abdelkader M. Al-Amri
  • Heyam S. Ali
  • Iqbal Ahmed
Original Article

Abstract

The differentiation between legal and illegal opiate product use through the detection of marker compounds in urine is one of the most important subjects in forensic toxicology. Thebaine, an opium alkaloid, can be detected by gas chromatography-mass spectrometry (GC-MS) and has been suggested as a good marker of poppy seed use in differentiation from that of illicit heroin. In the present study, thebaine was targeted as a urinary marker of opium use because it is a major constituent of opium. Although thebaine lacks the conventional functional group, it was found to form a trimethylsilyl (TMS) derivative. This has made it possible to simultaneously detect thebaine together with morphine and codeine in the same urine sample to confirm opium use, thus saving time and cost of analysis while using less material. The TMS derivatization was found to enhance the stability and chromatographic properties of thebaine and to increase the sensitivity of its detection about 50-fold in comparison with that of the underivatized compound. Using the present method, thebaine was analyzed for a number of actual urine samples obtained from users of opium, illicit heroin, or codeine preparation. The results showed that thebaine is a useful opium-use marker subject to its oral administration.

Keywords

Thebaine Urinary marker Opium use Oral route Trimethylsilyl derivatization GC-MS 

References

  1. 1.
    Al-Amri AM, Smith RM, El-Haj BM, Juma’a MAH (2004) GC-MS detection and characterization of reticuline as opium use marker. Forensic Sci Int 142:61–69PubMedCrossRefGoogle Scholar
  2. 2.
    Al-Amri AM, Smith RM, El-Haj BM (2005) The GC-MS detection and characterization of neopine resulting from opium use and codeine metabolism and its potential as an opiate-product-use marker. Anal Bioanal Chem 382:839–835CrossRefGoogle Scholar
  3. 3.
    Al-Amri AM (2004) Marker compounds in urine for opiate product use. Doctoral thesis, Department of Chemistry, Loughborough University, UKGoogle Scholar
  4. 4.
    Yeh SY, Gorodetzky CW, McQuinn RL (1976) Urinary excretion of heroin and its metabolites in man. J Pharmacol Exp Ther 196:249–256PubMedGoogle Scholar
  5. 5.
    Brenneisen R, Hasler F, Wursch D (2002) Acetylcodeine as a urinary marker to differentiate the use of street heroin and pharmaceutical heroin. J Anal Toxicol 26:561–566PubMedGoogle Scholar
  6. 6.
    Sweetman SC (ed) (2002) Martindale the complete drug reference, 33rd edn. Pharmaceutical, London, p 1333Google Scholar
  7. 7.
    Bogusz MJ, Maier RD, Erkens M, Kohls U (2001) Detection of non-prescription heroin markers in urine with liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. J Anal Toxicol 25:431–438PubMedGoogle Scholar
  8. 8.
    Mclachlan-Troup N, Taylor GW, Trathen BC (2001) Diamorphine treatment for opiate dependence: putative markers of contaminant heroin misuse. Addict Biol 6:223–231PubMedCrossRefGoogle Scholar
  9. 9.
    El-Haj BM, Al-Amri AM, Ali HS (2007) GC-MS detection and tentative characterization of two noscapine metabolites and their potential as markers for opium and illicit heroin use. Forensic Toxicol 25:22–29 DOI 10.1007/s11419-007-0023-9CrossRefGoogle Scholar
  10. 10.
    Tsunoda N, Yoshimura H (1979) Metabolic fate of noscapine, II. Isolation and identification of novel metabolites produced by C-C bond cleavage. Xenobiotica 9:181–187PubMedCrossRefGoogle Scholar
  11. 11.
    Tsunoda N, Yoshimura H (1981) Metabolic fate of noscapine III: further studies on identification and determination of the metabolites. Xenobiotica 11:23–32PubMedCrossRefGoogle Scholar
  12. 12.
    ElSohly HN, Stanford DF, Jones AB, ElSohly MA, Snyder H, Pedersen C (1988) Gas chromatography/mass spectrometric analysis of morphine and codeine in human urine of poppy seed eaters. J Forensic Sci 33:347–355PubMedGoogle Scholar
  13. 13.
    Cassella G, Wu AHB, Shaw BR, Hill DW (1997) The analysis of thebaine in urine for the detection of poppy seed consumption. J Anal Toxicol 21:376–383PubMedGoogle Scholar
  14. 14.
    Lewis RJ, Johnson RD, Hattrup RA (2005) Simultaneous analysis of thebaine, 6-MAM and six abused opiates in postmortem fluids and tissues using Zymark automated solidphase extraction and gas chromatography-mass spectrometry. J Chromatogr B 822:137–145CrossRefGoogle Scholar
  15. 15.
    Meadway C, George S, Braithwaite R (1998) Opiate concentration following the ingestion of poppy seed products—evidence for ‘the poppy seed defense’. Forensic Sci Int 96:29–38PubMedCrossRefGoogle Scholar
  16. 16.
    Johnson RD, Lewis J, Hattrup RA (2005) Poppy seed consumption or opiate use: the determination of thebaine and opiates of abuse in postmortem fluids and tissues. DOT/FAA/AM-05/11, Office of Aerospace Medicine, Washington DC, 20591. www.cami.jccbi.gov/aam-400a/Abstracts/2005/FULL20%TEXT/0511.pdf. Cited 7 December 2006Google Scholar
  17. 17.
    Schiff PL Jr (2002) Opium and its alkaloids. Am J Pharm Educ 66:186–194Google Scholar
  18. 18.
    Chen W, Wu H, Bernard D, Metcalf MD, Deschamps JR, Flippen L, Mackerell AD Jr, Coop A (2003) Rearrangement of 5-trimethylsilylthebaine on treatment with L-selectride: an efficient synthesis of (+)-bractazonine. J Org Chem 68:1929–1932PubMedCrossRefGoogle Scholar
  19. 19.
    Kushnir MM, Crockett DK, Nelson G, Urry FM (1999) Comparison of four derivatizing reagents for 6-acetylmorphine GC-MS analysis. J Anal Toxicol 23:262–269PubMedGoogle Scholar
  20. 20.
    Penton Z (2002) Derivatization of drugs prior to GC-MS analysis. Varian Product Information Bulletin, Application Note number MSP 2218, Palo Alto, CAGoogle Scholar
  21. 21.
    Yinon J (1995) Forensic applications of mass spectrometry. CRC, London, p 33Google Scholar
  22. 22.
    Regis Technologies (2000) GC derivatization. www.registech.com/gc/gcderrev.pdf. Cited 21 December 2006Google Scholar
  23. 23.
    Little JL (1999) Artifacts in trimethylsilyl derivatization reactions and ways to avoid them. J Chromatogr A 844:1–22PubMedCrossRefGoogle Scholar
  24. 24.
    Chen W, Parrish DA, Deschamps JR, Coop A (2005) Functionalization of the 6,14-bridge of the orvinols 1. Preparation of Diels-Alder reaction of 7-phenylsilylthebaine. Helv Chim Acta 88:822–829CrossRefGoogle Scholar
  25. 25.
    Soine WH (1986) Clandestine drug synthesis. Med Res Rev 6:41–74PubMedCrossRefGoogle Scholar
  26. 26.
    Fehn J, Megges G (1985) Detection of O 6-monoacetyl morphine in urine samples by GC-MS as evidence for heroin use. J Anal Toxicol 9:2–7Google Scholar
  27. 27.
    Cone EJ, Welch P, Mitchell JM, Paul D (1991) Forensic drug testing for opiates: I. Detection of 6-acetylmorphine in urine as an indicator of recent heroin exposure; drug and assay considerations and detection times. J Anal Toxicol 15:1–7PubMedGoogle Scholar
  28. 28.
    Westermeyer J (1987) Cultural patterns of drug and alcohol use: an analysis of host and agent in the cultural environment. UNODC Bull Narcotics 2:11–27Google Scholar
  29. 29.
    Wu F-F, Dobberstein RH (1977) Quantitative determination of thebaine in Papaver bracteatum by high-pressure liquid chromatography. J Chromatogr 140:65–70PubMedCrossRefGoogle Scholar

Copyright information

© Japanese Association of Forensic Toxicology 2007

Authors and Affiliations

  • Babiker M. El-Haj
    • 1
    Email author
  • Abdelkader M. Al-Amri
    • 1
  • Heyam S. Ali
    • 2
  • Iqbal Ahmed
    • 2
  1. 1.Sharjah Police Forensic Science LaboratorySharjahUnited Arab Emirates (UAE)
  2. 2.Dubai Pharmacy CollegeDubaiUAE

Personalised recommendations